Migraine prevention with beta-blockers: a placebo effect?
Gaudet
R J
RJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D004311:Double-Blind Method; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D010919:Placebos; D012107:Research Design
D000319:Adrenergic beta-Antagonists; D010919:Placebos